NCT02784795 2025-08-21A Study of LY3039478 in Participants With Advanced or Metastatic Solid TumorsEli Lilly and CompanyPhase 1 Terminated94 enrolled 28 charts
NCT02443337 2020-12-09A Study of LY3023414 and Necitumumab in Squamous Lung CancerEli Lilly and CompanyPhase 2 Terminated31 enrolled 14 charts